secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2021-07-08T23:59:59+00:00
Accession:  0001493152-21-016465
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity issues preliminary Q1 FY2022 revenue guidance: up >45% QoQ
---------------------------------------------------------------------

- Revenue for Q1 ended June 30, 2021 expected to increase >45% sequentially and >280% YoY.
- This would be the 9th consecutive quarter of revenue growth.
- Customer base expanded to 23 states from 17 states nine months ago.
- CEO cites accelerating sequential growth, high correlation between devices and TaaS revenue.
- Expects consistent triple-digit revenue growth for remainder of fiscal 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315221016465/0001493152-21-016465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315221016465/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-016465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer